Literature DB >> 19330875

Diagnosis, management, and treatment of hepatitis C: an update.

Marc G Ghany1, Doris B Strader, David L Thomas, Leonard B Seeff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19330875      PMCID： PMC7477893          DOI： 10.1002/hep.22759

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  413 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.

Authors:  E J Bini; S Mehandru
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

3.  A short course of pegylated interferon-alpha in acute HCV hepatitis.

Authors:  G Calleri; G Cariti; F Gaiottino; F G De Rosa; O Bargiacchi; S Audagnotto; S Quaglia; T De Blasi; P Romano; A Traverso; G Leo; R Carbone; B Del Mastro; M Tinelli; P Caramello; G Di Perri
Journal:  J Viral Hepat       Date:  2007-02       Impact factor: 3.728

4.  HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin.

Authors:  Beat Helbling; Wolfram Jochum; Ivan Stamenic; Marina Knöpfli; Andreas Cerny; J Borovicka; Jean-Jacques Gonvers; Martin Wilhelmi; Sabine Dinges; Beat Müllhaupt; Alicia Esteban; Beat Meyer-Wyss; Eberhard L Renner
Journal:  J Viral Hepat       Date:  2006-11       Impact factor: 3.728

5.  Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis.

Authors:  Dario Roccatello; Alessandro Fornasieri; Osvaldo Giachino; Daniela Rossi; Alessandra Beltrame; Giovanni Banfi; Roberto Confalonieri; Antonio Tarantino; Sonia Pasquali; Antonio Amoroso; Silvana Savoldi; Valeriana Colombo; Carlo Manno; Antonio Ponzetto; Luigi Moriconi; Antonello Pani; Roberto Rustichelli; Giovanni Barbiano Di Belgiojoso; Chiara Comotti; Maria Ida Quarenghi
Journal:  Am J Kidney Dis       Date:  2007-01       Impact factor: 8.860

6.  Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3.

Authors:  Mitchell L Shiffman; Anastasios A Mihas; Farida Millwala; Richard K Sterling; Velimir A Luketic; R Todd Stravitz; Arun J Sanyal
Journal:  Am J Gastroenterol       Date:  2007-02-23       Impact factor: 10.864

7.  Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.

Authors:  R Misiani; P Bellavita; D Fenili; O Vicari; D Marchesi; P L Sironi; P Zilio; A Vernocchi; M Massazza; G Vendramin
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

8.  Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

Authors:  Zachary D Goodman; Hala R Makhlouf; Lea Liu; William Balistreri; Regino P Gonzalez-Peralta; Barbara Haber; Maureen M Jonas; Parvathi Mohan; Jean P Molleston; Karen F Murray; Michael R Narkewicz; Philip Rosenthal; Lesley J Smith; Patricia R Robuck; Kathleen B Schwarz
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

9.  Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.

Authors:  Xavier Forns; Montserrat García-Retortillo; Trinidad Serrano; Anna Feliu; Francisco Suarez; Manuel de la Mata; Juan Carlos García-Valdecasas; Miquel Navasa; Antoni Rimola; Juan Rodés
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

10.  Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.

Authors:  Mitchell L Shiffman; Fredy Suter; Bruce R Bacon; David Nelson; Hugh Harley; Ricard Solá; Stephen D Shafran; Karl Barange; Amy Lin; Ash Soman; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2007-07-12       Impact factor: 91.245
View more
  943 in total

1.  Rate and factors affecting treatment uptake of patients with chronic hepatitis C in a tertiary referral hospital.

Authors:  Kenneth Kar-Lung Yan; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Henry Lik-Yuen Chan
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients.

Authors:  David R Nelson; Stefan Zeuzem; Pietro Andreone; Peter Ferenci; Robert Herring; Donald M Jensen; Patrick Marcellin; Paul J Pockros; Maribel Rodríguez-Torres; Lorenzo Rossaro; Vinod K Rustgi; Thomas Sepe; Mark Sulkowski; Isaac R Thomason; Eric M Yoshida; Anna Chan; George Hill
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

Review 3.  Interferon alpha for chronic hepatitis D.

Authors:  Zaigham Abbas; Muhammad Arsalan Khan; Mohammad Salih; Wasim Jafri
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

4.  FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.

Authors:  Keyur Patel; Mireen Friedrich-Rust; Yoav Lurie; Mircea Grigorescu; Carol Stanciu; Chuan-Mo Lee; Eugene R Schiff; Dieter Häussinger; Michael P Manns; Guido Gerken; Isabelle Colle; Michael Torbenson; Erik Pulkstenis; G Mani Subramanian; John G McHutchison; Stefan Zeuzem
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

5.  Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.

Authors:  Des Crowley; Walter Cullen; Eamon Laird; John S Lambert; Tina Mc Hugh; Carol Murphy; Marie Claire Van Hout
Journal:  J Transl Int Med       Date:  2017-06-30

6.  Early Experience of Sofosbuvir based Combination Therapy in "Real-Life" Cohort with Chronic Hepatitis-C Infection.

Authors:  Rajiv Mehta; Mayank Kabrawala; Subhash Nandwani; Rini Tekriwal; Payal Nandania
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program.

Authors:  Melissa R Stein; Irene J Soloway; Karen S Jefferson; Robert J Roose; Julia H Arnsten; Alain H Litwin
Journal:  J Subst Abuse Treat       Date:  2012-10-02

Review 8.  Hepatitis C virus: an overview for dental health care providers.

Authors:  R Monina Klevens; Anne C Moorman
Journal:  J Am Dent Assoc       Date:  2013-12       Impact factor: 3.634

Review 9.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

10.  Role of genetic polymorphisms in hepatitis C virus chronic infection.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Caterina Sagnelli; Lorenzo Onorato; Evangelista Sagnelli
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.